tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Annexon reports Q2 EPS (34c), consensus (36c)
PremiumThe FlyAnnexon reports Q2 EPS (34c), consensus (36c)
2M ago
Annexon completes enrollment in Phase 3 ARCHER II trial
Premium
The Fly
Annexon completes enrollment in Phase 3 ARCHER II trial
2M ago
Annexon tells Wells Fargo doctor tweet not factural
Premium
The Fly
Annexon tells Wells Fargo doctor tweet not factural
3M ago
Annexon price target lowered to $14 from $20 at H.C. Wainwright
PremiumThe FlyAnnexon price target lowered to $14 from $20 at H.C. Wainwright
5M ago
Annexon Biosciences: Promising Growth Potential with Key Catalysts and Strategic FDA Interactions
Premium
Ratings
Annexon Biosciences: Promising Growth Potential with Key Catalysts and Strategic FDA Interactions
5M ago
Annexon Biosciences: Buy Rating Driven by Regulatory Milestones and Promising Pipeline Developments
Premium
Ratings
Annexon Biosciences: Buy Rating Driven by Regulatory Milestones and Promising Pipeline Developments
5M ago
Annexon announces tanruprubart trial meets primary endpoint
PremiumThe FlyAnnexon announces tanruprubart trial meets primary endpoint
6M ago
Needham healthcare analysts hold analyst/industry conference call
Premium
The Fly
Needham healthcare analysts hold analyst/industry conference call
6M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100